Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 420,323 |
|
|||||
| News | (1) | ||||||
| Day High | 12.39 | Low High |
|||||
| Day Low | 12.02 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NovoCure Ltd | NVCR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.285 | 2.36% | 12.34 | 13:50:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.09 | 12.02 | 12.39 | 12.055 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,745 | 420,323 | $ 12.23 | $ 5,138,853 | - | 10.87 - 83.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:49:59 | 6 | $ 12.33 | USD |
NovoCure Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.31B | 107.09M | - | 509.34M | -207.04M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NovoCure News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVCR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.40 | 12.46 | 11.70 | 12.02 | 1,050,152 | -0.06 | -0.48% |
| 1 Month | 14.78 | 16.05 | 11.70 | 14.12 | 1,785,868 | -2.44 | -16.51% |
| 3 Months | 14.09 | 18.04 | 11.70 | 14.62 | 1,291,696 | -1.75 | -12.42% |
| 6 Months | 14.14 | 18.04 | 10.87 | 13.91 | 1,367,460 | -1.80 | -12.73% |
| 1 Year | 62.93 | 83.60 | 10.87 | 25.15 | 1,512,045 | -50.59 | -80.39% |
| 3 Years | 208.82 | 232.76 | 10.87 | 60.86 | 943,784 | -196.48 | -94.09% |
| 5 Years | 45.09 | 232.76 | 10.87 | 76.50 | 932,953 | -32.75 | -72.63% |
NovoCure Description
| NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. |
